New Teduglutide Publication on Pediatric Short Bowel Syndrome Response

A new publication involving teduglutide was published on October 21, 2026. The study, titled "Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials," appeared in the journal Intestinal Failure. The publication is described as a post hoc analysis of open-label long-term extension trials. It focuses on characteristics associated with response to teduglutide in pediatric patients with short bowel syndrome-associated intestinal failure. No specific findings or outcomes from the analysis are detailed in the available event data. Teduglutide remains an approved compound. This entry reflects only the existence and bibliographic details of the publication as provided. Readers interested in the broader context of teduglutide, including its approved uses and prior research, can consult the compound overview for additional background.